Associations between the mismatch-negativity component and symptom severity in children and adolescents with attention deficit/hyperactivity disorder

被引:21
|
作者
Yamamuro, Kazuhiko [1 ]
Ota, Toyosaku [1 ]
Iida, Junzo [2 ]
Nakanishi, Yoko [1 ]
Kishimoto, Naoko [1 ]
Kishimoto, Toshifumi [1 ]
机构
[1] Nara Med Univ, Sch Med, Dept Psychiat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan
[2] Nara Med Univ, Sch Med, Fac Nursing, Kashihara, Nara, Japan
来源
关键词
attention deficit/hyperactivity disorder; event-related potentials; mismatch negativity; symptom severity; relationship; DEFICIT HYPERACTIVITY DISORDER; EVENT-RELATED POTENTIALS; RESPONSE-INHIBITION; SCHIZOPHRENIA; METHYLPHENIDATE; P300; MMN; ABNORMALITIES; CONNECTIVITY; PARADIGM;
D O I
10.2147/NDT.S120540
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim: Cognitive impairment is an important predictor of functional outcome in patients with attention deficit/hyperactivity disorder (ADHD). However, the neurophysiology of ADHD-related cognitive impairments remains unclear. Event-related potentials (ERPs) represent the noninvasive measurement of neural correlates of cognitive function. Mismatch negativity (MMN) is an ERP component that is presumed to index the preattentive monitoring of changes in the auditory environment. Materials and methods: Previous studies have shown altered MMN amplitude and latency in patients with ADHD. However, little is known about the relationship between MMN and ADHD-symptom severity. To address this, we measured the amplitude and latency of MMN in ERPs and assessed correlations with the clinical severity of ADHD, as measured by the ADHD Rating Scale IV-Japanese version. Participants were 51 treatment-naive children and adolescents with ADHD (mean age 10.42 +/- 3.35 years) and 15 normally developing age-and sex-matched children (mean age 11.89 +/- 3.36 years). Results: In the ADHD group, MMN amplitudes were attenuated at the central electrode and MMN latencies prolonged at the parietal electrode (Pz) relative to those in the control group. Furthermore, MMN amplitudes at Pz were negatively correlated with ADHD full-scale and hyperactivity-impulsivity and inattention subscale scores, and MMN latency at Pz was positively correlated with ADHD hyperactivity-impulsivity subscale scores. Conclusion: Our data suggest that MMN reflects the severity of ADHD symptoms in children and adolescents, and provides support for the use of ERPs in evaluating ADHD symptoms in patients.
引用
收藏
页码:3183 / 3190
页数:8
相关论文
共 50 条
  • [31] Internet Gaming Disorder in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Berloffa, Stefano
    Salvati, Andrea
    D'Acunto, Giulia
    Fantozzi, Pamela
    Inguaggiato, Emanuela
    Lenzi, Francesca
    Milone, Annarita
    Muratori, Pietro
    Pfanner, Chiara
    Ricci, Federica
    Ruglioni, Laura
    Tacchi, Annalisa
    Tessa, Chiara
    Villafranca, Arianna
    Masi, Gabriele
    CHILDREN-BASEL, 2022, 9 (03):
  • [32] Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective
    Setyawan, Juliana
    Fridman, Moshe
    Hodgkins, Paul
    Quintero, Javier
    Erder, M. Haim
    Katic, Bozena J.
    Harpin, Valerie
    ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS, 2015, 7 (01) : 75 - 87
  • [33] Impulsive Aggression in Attention-Deficit/Hyperactivity Disorder: Symptom Severity, Co-Morbidity, and Attention-Deficit/Hyperactivity Disorder Subtype
    Connor, Daniel F.
    Chartier, Karen G.
    Preen, Ellen C.
    Kaplan, Richard F.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (02) : 119 - 126
  • [34] Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
    Storebo, Ole Jakob
    Storm, Maja Rosenberg Overby
    Ribeiro, Johanne Pereira
    Skoog, Maria
    Groth, Camilla
    Callesen, Henriette E.
    Schaug, Julie Perrine
    Rasmussen, Pernille Darling
    Huus, Christel-Mie L.
    Zwi, Morris
    Kirubakaran, Richard
    Simonsen, Erik
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (03):
  • [35] Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
    Storebo, Ole Jakob
    Ramstad, Erica
    Krogh, Helle B.
    Nilausen, Trine Danvad
    Skoog, Maria
    Holmskov, Mathilde
    Rosendal, Susanne
    Groth, Camilla
    Magnusson, Frederik L.
    Moreira-Maia, Carlos R.
    Gillies, Donna
    Rasmussen, Kirsten Buch
    Gauci, Dorothy
    Zwi, Morris
    Kirubakaran, Richard
    Forsbol, Bente
    Simonsen, Erik
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (11):
  • [36] Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder
    Witcher, JW
    Long, A
    Smith, B
    Sauer, JM
    Heilgenstein, J
    Wilens, T
    Spencer, T
    Biederman, J
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) : 53 - 63
  • [37] Efficacy of atomoxetine in children and adolescents with attention deficit/hyperactivity disorder
    Yamamuro, K.
    Ueda, J.
    Takada, R.
    Yoshikawa, H.
    Aoki, C.
    Inoue, Y.
    Azechi, T.
    Yamamoto, S.
    Furuyama, T.
    Kishimoto, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S713 - S714
  • [38] Psychiatric Comorbidity in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Herguner, Sabri
    Herguner, Arzu
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2012, 49 (02): : 114 - 118
  • [39] Efficacy of Attention Deficit Hyperactivity Disorder treatments in children and adolescents
    Jarque Fernandez, Sonia
    ANUARIO DE PSICOLOGIA, 2012, 42 (01): : 19 - U134
  • [40] Effectiveness of strattera in children and adolescents with attention deficit hyperactivity disorder
    Vakula, I. N.
    Vasyanina, Yu Sh.
    Gorbunova, Z. H.
    Nikiforova, E. Yu.
    Ponomarenko, E. I.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2009, 109 (08) : 42 - 44